Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc

Bullboard Posts

Comment by ciretaka198on Jan 29, 2016 10:17am

76 Views

Post# 24505242

RE:Nice opening BID size if it holds

Microbix licenses rabies vaccine to Ontario govenment

Research Money

August 25, 1999 | Anonymous | Copyright

Microbix Biosystems Inc, Toronto, has signed a licence agreement with the Ontario Ministry of Natural Resources for its rabies vaccine which will be developed initially as an oral vaccine for raccoons. Microbix will receive an upfront fee and royalties based on subsequent sales in Canada, the US and Mexico. …

Bullboard Posts

Canadian government to fund Electric Royalties portfolio property